Skip to main content
. 2022 Nov 21;12(11):e062570. doi: 10.1136/bmjopen-2022-062570

Table 1.

Descriptive statistics of the whole sample demographics at consent (age) and baseline assessments

Variable N M SD Min Max
Age (at consent) 46 27.30 8.17 18 50
Gender (male) 33 (71.74%)
Gender (female) 13 (28.26%)
Age of illness onset (years) 46 26.53 8.45 18 49
Duration from 1st psychotic symptom (days) to baseline antipsychotic (DUP) 46 248.30 245.06 0 726
Duration from 1st contact with mental health services (days) to baseline antipsychotic 46 346.57 600.37 6 2358
Chlorpromazine equivalents (mg/day) 46 176.89 121.29 10 800
Number of hospital admissions 46 0.89 0.64 0 3
Years of education 42 13.62 2.82 5 20
CGI-SCH baseline score 56 Minimally ill=1
Mildly ill=4
Moderately ill=12
Markedly ill=15
Severely ill=12
Among the most severely ill=1
Antipsychotic medication 51 Amisulpride=1
Aripiprazole=19
Olanzapine=16
Paliperidone=1
Quetiapine=4
Risperidone=5

CGI-SCH, Clinician Rating Scale for Schizophrenia; DUP, duration of untreated psychosis.